Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Most GLP-1 medications (semaglutide, liraglutide, dulaglutide) do not directly reduce contraceptive efficacy
Assuming everyone took it, made no lifestyle changes and gained back more than half of the weight after discontinuation with no use as a maintenance drug afterwards, utilizing a very pessimistic penetration rate of 15%, even then it would be enough to have the obesity rate correct lower by more than 6%
The latter should not replace proper medical assessment when persistent digestive problems occur
Aim for 0.8 to 1.0 grams of protein per pound of your target body weight each day
The details ( Evidence, limitations, Mechanisms and massage for patients) in first 4 comments What this means for users/patients +If someone is being treated with semaglutide and has risk factors for optic nerve issues (for example: previous NAION in one eye, glaucoma, optic disc crowding, severe diabetic retinopathy, major vascular disease), then this potential risk should be discussed with their ophthalmologist and prescribing physician
A study shows that GLP-1 receptor agonists show a notably reduced incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the requirement for first-line glaucoma treatments compared to metformin in individuals with type 2 diabetes (80)
